inositol has been researched along with Oligomenorrhea in 4 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Oligomenorrhea: Abnormally infrequent menstruation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effects of D-Chiro-Inositol in women affected by polycystic ovary syndrome (PCOS)." | 7.81 | Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol. ( Barbaro, L; Laganà, AS; Pizzo, A, 2015) |
| "Our study showed that both myo-inositol (MI-PG) and D-chiro inositol (DCI-PG) treatments are able to significantly improve the regularity of the menstrual cycle, the Acne Score, the endocrine and metabolic parameters and the insulin-resistence in young, overweight, PCOS patients." | 5.20 | Myo-inositol vs. D-chiro inositol in PCOS treatment. ( Ciotta, L; Formuso, C; Stracquadanio, M, 2015) |
| "Myo-inositol and D-chiro-inositol are capable of improving the ovarian function and metabolism of polycystic ovary syndrome (PCOS) patients." | 5.19 | Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS. ( Barbaro, L; Laganà, AS; Pizzo, A, 2014) |
| "To evaluate the effects of D-Chiro-Inositol in women affected by polycystic ovary syndrome (PCOS)." | 3.81 | Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol. ( Barbaro, L; Laganà, AS; Pizzo, A, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stracquadanio, M | 2 |
| Ciotta, L | 2 |
| Palumbo, MA | 1 |
| Pizzo, A | 2 |
| Laganà, AS | 2 |
| Barbaro, L | 2 |
| Formuso, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Inositols on Insulin Resistance in Children With Obesity (ONIRICO Trial)[NCT05701813] | 56 participants (Anticipated) | Interventional | 2023-02-01 | Not yet recruiting | |||
| Treatment of Functional Ovarian Cyst Randomised Clinical Trial[NCT05244811] | Phase 3 | 60 participants (Anticipated) | Interventional | 2022-02-20 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for inositol and Oligomenorrhea
| Article | Year |
|---|---|
Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
Topics: Adolescent; Adult; Amenorrhea; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Follicl | 2014 |
Myo-inositol vs. D-chiro inositol in PCOS treatment.
Topics: Acne Vulgaris; Adult; Double-Blind Method; Female; Hirsutism; Humans; Inositol; Insulin Resistance; | 2015 |
2 other studies available for inositol and Oligomenorrhea
| Article | Year |
|---|---|
Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients.
Topics: Adult; Blood Glucose; Body Mass Index; Body Weight; Drug Therapy, Combination; Female; Humans; Hyper | 2018 |
Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol.
Topics: Adult; Blood Glucose; Female; Folic Acid; Follicle Stimulating Hormone; Humans; Inositol; Luteinizin | 2015 |